Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Heshmati, Javad; Namazi, Nazli; Memarzadeh, Mohammad Reza; Taghizadeh, Mohsen; Kolahdooz, Fariba

doi:10.1016/j.foodres.2015.01.030

Cited by 100 publications

(122 citation statements)

References 28 publications

Supporting

Mentioning

107

Contrasting

Unclassified

Order By: Relevance

“…Lipid profiles constitute one of the most important factors that can be changed in many diseases and are used to evaluate conditions of the patients and subjects (Mohtashami and Entezari, 2016). In our review, Nigella sativa supplement can change lipid profiles significantly in different conditions (Heshmati et al, 2015;Ibrahim et al, 2014;Qibi et al, 2006;Najmi et al, 2012;Tasawar et al, 2011;Kaatabi et al, 2012;Najmi et al, 2008;Bhatii et al, 2009;Sabzghabaee et al, 2012;Datau et al, 2010;Qidwai W et al, 2009;Dehkordi FR et al, 2008;Bamosa et al, 1997;Ahmed et al, 2012).…”

Section: Discussionmentioning

confidence: 80%

“…The age range of the participants in trials was 18-yea0rs old. Supplementation with NS oil can significantly improve lipid profile in hyperlipidemic patients with T2DM (Heshmati et al, 2015;Kaatabi et al, 2012;Ahmed et al, 2012), with menopausal women (Ibrahim et al, 2014), with metabolic syndrome (Najmi et al, 2012;Najmi et al, 2008), and with coronary heart disease (Tasawar et al, 2011). However, no complications caused by NS were observed in all studies (Table 2).…”

Section: Resultsmentioning

confidence: 96%

“…In one trial study (Heshmati et al, 2015) reported that NS oil decreased LDL-C and TG levels after 3months while other previous studies reported different effects of NS on lipid parameters. Kaatabi et al (2012) evaluated different dosages of powdered NS (1, 2 and 3 g/day) in patients with type 2 diabetes.…”

Section: Discussionmentioning

confidence: 94%

“…The treatment group showed significant improvement with reference to total xcholestrol, low density lipoprotein, (LDL All studies were clinical trials and have been conducted on different patients and subjects (Heshmati et al, 2015;Ibrahim et al, 2014;Qibi et al, 2006;Najmi et al, 2012;Tasawar et al, 2011;Kaatabi et al, 2012;Najmi et al, 2008;Bhatii et al, 2009;Sabzghabaee et al, 2012;Datau et al, 2010;Qidwai et al, 2009;Dehkordi et al, 2008;Bamosa et al, 1997;Ahmed et al, 2012). Information of these studies is summarized in the table 2.…”

Section: Resultsmentioning

confidence: 99%

“…The total number of subjects in these trials was 738 from different conditions and diseases as hyperlipidemia in diabetic patients (Heshmati et al, 2015;Kaatabi et al, 2012;Ahmed et al, 2012), menopausal women (Ibrahim et al, 2014), metabolic syndrome (Najmi et al, 2012;Najmi et al, 2008) and coronary heart disease (Tasawar et al, 2011). The duration of the trials was between 2 weeks-3 months.…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Effect of Nigella sativa supplementation on human lipids: systematic review

Al-Naggar

Osman

Mohamed³

et al. 2017

J App Pharma Sci

View full text Add to dashboard Cite

Nigella sativa (NS) is widely used in traditional medicine and several studies have been conducted to reveal NS effects on different medical disorders including hyperlipidemia. Since hyperlipidemia is a common risk factor for the development of cardiovascular illness. We evaluated the effects of NS supplementation on lipid profile in clinical trial performed among humans. A search on published studies was done by using databases including Scopus, PubMed, Google Scholar, Thomas Reuters Web of Science, and CINAHIL. Terms searched included "Nigella sativa, Black seed, Black cumin, Triglycerides, Cholesterol, Lipoproteins". Initially 432 articles were extracted. However, four hundred eighteen papers were unrelated, reviews, animal studies, combined and duplicated studies were excluded, and finally only fourteen articles were eligible for this review. After analysing 14 articles including 738 participants from different countries and nations. Results of these clinical trials revealed that Nigella sativa is effective to change the lipid profile significantly in different conditions. This systematic review revealed that Nigella sativa supplementation might be effective in hyperlipidemic control in humans and seems potential target of future drug for hyperlipidemic conditions.

show abstract

Section: Discussionmentioning

confidence: 80%

Section: Resultsmentioning

confidence: 96%

Section: Discussionmentioning

confidence: 94%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Effect of Nigella sativa supplementation on human lipids: systematic review

Al-Naggar

Osman

Mohamed³

et al. 2017

J App Pharma Sci

View full text Add to dashboard Cite

show abstract

LC‐MS based metabolite profiling, in‐vitro antioxidant and in‐vivo antihyperlipidemic activity ofNigella sativaextract

Shrivastava

Shrestha

Pokhrel

et al. 2023

eFood

View full text Add to dashboard Cite

The aim of this study was to identify the bioactive phytoconstituents present in the aqueous extract of Nigella sativa and also, to evaluate the antioxidant and antihyperlipidemic activity in Wistar rats. The LC‐MS/MS analysis was assessed for the determination of different bioactive compounds present in N. sativa extract. Total phenolic and flavonoid content were determined by using validated Folin‐Ciocalteu and Aluminum chloride colorimetric methods, respectively. The in‐vitro antioxidant and in‐vivo antihyperlipidemic activity in Wistar rats were also evaluated. Preliminary phytochemical screening of the extract showed the presence of alkaloids, flavonoids, phenols, glycosides, and amino acids in the aqueous extract. The bioactive compounds of the aqueous extract were identified through LC‐MS/MS analysis. The in‐vitro antioxidant activity of N. sativa showed the highest free radical scavenging capacity in DPPH, H2O2, and OH radical scavenging assays with IC50 values 11.916 ± 2.828, 30.294 ± 13.790, and 12.048 ± 2.828 µg/mL, respectively. Evaluation of antihyperlipidemic activity of extract in Wistar rats showed that a high dose (800 mg/kg) of extract significantly decreased total cholesterol (TC) 71.76 ± 6.91 mg/dL, TG 83.6 ± 8.09 mg/dL, low‐density lipoproteins (LDL‐c) 33.86 ± 6.05 mg/dL, very low‐density lipoproteins (VLDL‐c) 16.72 ± 1.61 mg/dL level in blood. However, the HDL‐C level was significantly improved (21.18 ± 1.80 mg/dL) as compared to HFD‐induced control rats (11.76 ± 1.14 mg/dL) after 28 days of treatment. Also, at the same dose, animal body weight was also decreased to 162.6 ± 16.40 g compared with control 184.4 ± 10.24 g. The aqueous extract of N. sativa was found to be an effective natural source of antioxidant and hypolipidemic agents. This activity was attributed to the presence of diverse bioactive compounds in it.

show abstract

Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low‐Calorie Diet in Obese Women: A Randomized, Double‐Blind Controlled Clinical Trial

Namazi

Mahdavi

Alizadeh

et al. 2015

Phytotherapy Research

Self Cite

View full text Add to dashboard Cite

The aim of the present study was to determine the effects of Nigella sativa (NS) oil concurrent with a low-calorie diet on lipid peroxidation and oxidative status in obese women. In this double-blind placebo-controlled randomized clinical trial, 50 volunteer obese (body mass index = 30-35 kg/m(2)) women aged 25-50 years old were recruited. Participants were randomly divided into intervention (n = 25) and placebo (n = 25) groups. They received a low-calorie diet with 3 g/day NS oil or low-calorie diet with 3 g/day placebo for 8 weeks. Forty-nine women (intervention group = 25; placebo group = 24) completed the trial. NS oil concurrent with a low-calorie diet decreased weight in the NS group compared to the placebo group (-4.80 ± 1.50 vs. -1.40 ± 1.90 kg; p < 0.01). Comparison of red blood cell superoxidase dismutase (SOD) indicated significant changes in the NS group compared to the placebo group at the end of the study (88.98 ± 87.46 vs. -3.30 ± 109.80 U/gHb; p < 0.01). But no significant changes in lipid peroxidation, glutathione peroxidase, and total antioxidant capacity concentrations were observed. NS oil concurrent with a low-calorie diet decreased weight and increased SOD levels in obese women. However, more studies are suggested to confirm the positive effects of NS in obesity and its complications.

show abstract

Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Cited by 100 publications

References 28 publications

Effect of Nigella sativa supplementation on human lipids: systematic review

Effect of Nigella sativa supplementation on human lipids: systematic review

LC‐MS based metabolite profiling, in‐vitro antioxidant and in‐vivo antihyperlipidemic activity ofNigella sativaextract

Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low‐Calorie Diet in Obese Women: A Randomized, Double‐Blind Controlled Clinical Trial

Contact Info

Product

Resources

About